DAL FERRO, MATTEO
 Distribuzione geografica
Continente #
EU - Europa 4.355
NA - Nord America 3.981
AS - Asia 3.417
SA - Sud America 467
AF - Africa 123
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 1
Totale 12.361
Nazione #
US - Stati Uniti d'America 3.877
IT - Italia 1.710
SG - Singapore 1.254
CN - Cina 896
PL - Polonia 695
DE - Germania 386
VN - Vietnam 379
BR - Brasile 355
HK - Hong Kong 277
GB - Regno Unito 254
FR - Francia 234
NL - Olanda 216
KR - Corea 200
SE - Svezia 191
FI - Finlandia 166
RU - Federazione Russa 113
IN - India 95
IE - Irlanda 67
ES - Italia 56
CH - Svizzera 55
CA - Canada 52
MA - Marocco 48
BG - Bulgaria 46
AR - Argentina 43
AT - Austria 43
JP - Giappone 42
BD - Bangladesh 39
TR - Turchia 37
ID - Indonesia 36
MX - Messico 33
UA - Ucraina 29
ZA - Sudafrica 27
GR - Grecia 22
IQ - Iraq 20
CL - Cile 16
AU - Australia 15
EG - Egitto 15
EC - Ecuador 14
PK - Pakistan 13
SA - Arabia Saudita 13
TW - Taiwan 13
BE - Belgio 10
PY - Paraguay 10
CO - Colombia 9
JO - Giordania 9
PH - Filippine 9
RO - Romania 9
VE - Venezuela 9
AE - Emirati Arabi Uniti 8
CZ - Repubblica Ceca 8
AL - Albania 7
IL - Israele 7
NP - Nepal 7
TH - Thailandia 7
AZ - Azerbaigian 6
KE - Kenya 6
KZ - Kazakistan 6
LV - Lettonia 6
UY - Uruguay 6
UZ - Uzbekistan 6
GE - Georgia 5
IR - Iran 5
PT - Portogallo 5
BY - Bielorussia 4
DZ - Algeria 4
KG - Kirghizistan 4
LB - Libano 4
MY - Malesia 4
RS - Serbia 4
SN - Senegal 4
DK - Danimarca 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
LK - Sri Lanka 3
OM - Oman 3
PE - Perù 3
SK - Slovacchia (Repubblica Slovacca) 3
AM - Armenia 2
AO - Angola 2
BO - Bolivia 2
CR - Costa Rica 2
CY - Cipro 2
GA - Gabon 2
KW - Kuwait 2
LT - Lituania 2
LU - Lussemburgo 2
MD - Moldavia 2
NG - Nigeria 2
NI - Nicaragua 2
PA - Panama 2
QA - Qatar 2
SI - Slovenia 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
BB - Barbados 1
BF - Burkina Faso 1
BZ - Belize 1
CG - Congo 1
CI - Costa d'Avorio 1
CU - Cuba 1
Totale 12.341
Città #
Singapore 722
Warsaw 627
Ashburn 588
San Jose 330
Trieste 295
Chandler 276
Hong Kong 262
Hefei 200
Seoul 189
Beijing 185
Dallas 182
Milan 172
Fairfield 170
Munich 169
Chicago 121
Ho Chi Minh City 120
Woodbridge 120
Los Angeles 118
Council Bluffs 105
Seattle 101
Helsinki 98
Boardman 94
Rome 91
Cambridge 87
London 85
Wilmington 84
Houston 81
Hanoi 76
Lauterbourg 67
Ann Arbor 65
New York 65
Turin 64
Dublin 63
Santa Clara 60
Zgierz 56
Frankfurt am Main 52
Princeton 49
Columbus 48
Amsterdam 47
Sofia 46
Moscow 43
São Paulo 43
Casablanca 41
Shanghai 38
Bologna 37
Venice 37
Bern 35
The Dalles 34
Lappeenranta 32
Orem 32
Da Nang 31
Phoenix 31
Vienna 31
Redmond 29
Nuremberg 28
Buffalo 26
Florence 26
Turku 26
Denver 25
Düsseldorf 25
Jacksonville 23
Redondo Beach 23
Udine 22
Tokyo 21
Bremen 19
Genoa 19
Montreal 19
Chennai 18
Padova 18
Guangzhou 17
Dearborn 16
Dong Ket 16
Poplar 16
Toronto 16
Athens 15
Atlanta 15
Mumbai 15
Salt Lake City 15
Dhaka 14
Jakarta 14
Palermo 14
Utrecht 14
Boydton 13
Brooklyn 13
Grafing 13
Izmir 13
Jinan 13
Paris 13
Washington 13
Berlin 12
Elk Grove Village 12
Pune 12
Stockholm 12
Edinburgh 11
Naples 11
Pescara 11
Rio de Janeiro 11
Verona 11
Johannesburg 10
Manchester 10
Totale 7.673
Nome #
Cardioprotective factors against myocardial infarction selected in vivo from an AAV secretome library 678
Il Registro Regionale delle Morti Cardiache Improvvise in età giovanile del Friuli Venezia Giulia. Protocolli operativi e risultati di un progetto multidisciplinare 612
AAV-mediated in vivo functional selection of tissue-protective factors against ischaemia 516
Cardiac fluid dynamics meets deformation imaging 466
Inquadramento e gestione delle cardiomiopatie: il protocollo della Cardiologia di Trieste 402
Facciamo il punto: miocardio non compatto 372
MiR-320a as a Potential Novel Circulating Biomarker of Arrhythmogenic CardioMyopathy 338
Genetic Risk of Arrhythmic Phenotypes in Patients With Dilated Cardiomyopathy 337
Left Ventricular Response to Cardiac Resynchronization Therapy: Insights From Hemodynamic Forces Computed by Speckle Tracking 295
High prevalence of subtle systolic and diastolic dysfunction in genotype-positive phenotype-negative relatives of dilated cardiomyopathy patients 286
In Vivo Functional Selection Identifies Cardiotrophin-1 as a Cardiac Engraftment Factor for Mesenchymal Stromal Cells 247
Chapter 5: Genetics of Dilated Cardiomyopathy: Current Knowledge and Future Perspectives 246
Genetics of Dilated Cardiomyopathy: Clinical Implications 242
Regional Variation in RBM20 Causes a Highly Penetrant Arrhythmogenic Cardiomyopathy 225
Cardiac Magnetic Resonance Feature-Tracking Identifies Preclinical Abnormalities in Hypertrophic Cardiomyopathy Sarcomere Gene Mutation Carriers 213
Genetic and Phenotypic Characterization of Nexilin (NEXN)-Related Cardiomyopathy: Results From a Multicentric Study 210
Prevalence and evolution of right ventricular dysfunction among different genetic backgrounds in dilated cardiomyopathy 205
Role of the Electrocardiogram in Differentiating Genetically Determined Dilated Cardiomyopathy from Athlete's Heart 203
Terapia di modulazione della contrattilità cardiaca: basi molecolari e razionale per l’impiego in modelli di insufficienza cardiaca sistolica e diastolica 200
Association of Titin Variations with Late-Onset Dilated Cardiomyopathy 196
Echocardiographic evaluation of centenarians in Trieste 188
Evolving trends in epidemiology and natural history of cardiac amyloidosis: 30-year experience from a tertiary referral center for cardiomyopathies 169
Apoptosis, a useful marker in the management of hot-phase cardiomyopathy? 169
Clinical Risk Score to Predict Pathogenic Genotypes in Patients With Dilated Cardiomyopathy 165
Preserved skeletal muscle mitochondrial function, redox state, inflammation and mass in obese mice with chronic heart failure 159
Cardiomyopathies in children: Classification, diagnosis and treatment 158
Myocarditis: Which Role for Genetics? 157
Phenotypic Expression, Natural History and Risk Stratification of Cardiomyopathy Caused by Filamin C Truncating Variants 157
Arrhythmic risk stratification in non-ischaemic dilated cardiomyopathy 155
Hot Phases Cardiomyopathy: Pathophysiology, Diagnostic Challenges, and Emerging Therapies 155
Prognostic role of exercise intensity in familial Filamin C truncating variants 153
Arrhythmic Risk Stratification of Carriers of Filamin C Truncating Variants 151
Prognostic Prediction of Genotype vs Phenotype in Genetic Cardiomyopathies 147
Impact of DCM-Causing Genetic Background on Long-Term Response to Cardiac Resynchronization Therapy 146
Cardiology of the future: xenotransplantation with porcine heart 141
Lymphocytic Myocarditis: A Genetically Predisposed Disease? 141
n-3 PUFA-Enriched Diet Preserves Skeletal Muscle Mitochondrial Function and Redox State and Prevents Muscle Mass Loss in Mice with Chronic Heart Failure 140
Natural history of dilated cardiomyopathy: from asymptomatic left ventricular dysfunction to heart failure--a subgroup analysis from the Trieste Cardiomyopathy Registry. 140
Magnetic Resonance Imaging Characterization and Clinical Outcomes of Dilated and Arrhythmogenic Left Ventricular Cardiomyopathies 140
Critical analysis of the 2023 ESC guidelines on cardiomyopathy management 136
Prognostic value of echocardiographic evaluation of cardiac mechanics in patients with aortic stenosis and preserved left ventricular ejection fraction 133
Importance of genotype for risk stratification in arrhythmogenic right ventricular cardiomyopathy using the 2019 ARVC risk calculator 130
The Arrhythmic Phenotype in Cardiomyopathy 128
Whole-exome sequencing: Clinical characterization of pediatric and adult Italian patients affected by different forms of hereditary cardiovascular diseases 128
Toward standardization of echocardiography for the evaluation of left ventricular function in adult rodents: a position paper of the ESC Working Group on Myocardial Function 121
SARS-CoV-2, myocardial injury and inflammation: insights from a large clinical and autopsy study 120
Generation of human induced pluripotent stem cell line EURACi015-A from a patient affected by dilated cardiomyopathy carrying the Lamin A/C p.Glu161Lys mutation 119
Sport and Exercise in Genotype positive (+) Phenotype negative (-) Individuals. Current Dilemmas and Future Perspectives 119
Exercise Intensity and Cardiac Disease Development in carriers of Titin variants 117
Acute heart failure: mechanisms and pre-clinical models-a Scientific Statement of the ESC Working Group on Myocardial Function 112
Fenotypic expressions and clinical manifestations of arrhythmogenic cardiomyopathy 112
Role of arrhythmic phenotype in prognostic stratification and management of dilated cardiomyopathy 110
A European Delphi Consensus on the Management of Abdominal Aortic Aneurysms in Patients with Heritable Aortic Diseases 110
Heart failure with reduced ejection fraction and monogenic dilated cardiomyopathy: distinct diseases? Insights from randomized controlled trials 104
Genetic testing in cardiomyopathies: updates and future perspectives 99
Generation of iPSC lines (ICHi001-A, ICHi002-A, ICHi003-A, ICHi004-A) from four patients carrying Titin truncating variants associated with dilated cardiomyopathy 97
Lamin A/C Cardiomyopathy: Cutting Edge to Personalized Medicine 96
Genetic tracing and topography of spontaneous and stimulated cardiac regeneration in mice 93
The contribution of cardiopulmonary exercise testing in the familial screening for dilated and non-dilated left ventricular cardiomyopathies: case series 91
Prediction and prognostic role of left ventricular systolic dysfunction in family screening for dilated cardiomyopathy and non-dilated left ventricular cardiomyopathy 87
Genetic Landscape of Patients With Dilated Cardiomyopathy and a Systemic Immune-Mediated Disease 84
Assessing the influence of smoking on inflammatory markers in bacillus Calmette Guérin response among bladder cancer patients: a novel machine-learning approach 82
Clustering in dilated cardiomyopathy at initial evaluation: An effective tool for clinical stratification 78
Major arrhythmias in non-dilated left ventricular cardiomyopathy: a novel prediction score 77
The heart of dystrophinopathies 64
Risks of Ventricular Arrhythmia and Heart Failure in Carriers of RBM20 Variants 64
Titin-related familial dilated cardiomyopathy: factors associated with disease onset 58
Titin Cardiomyopathy, Emerging Evidence: More Than A Big Heart 57
Enhanced prognostic value of four‐tier hybrid grading system in Ta non‐muscle‐invasive bladder cancer 56
Unveiling the spectrum of sudden cardiac death: a multidisciplinary analysis from the Friuli Venezia Giulia registry 50
Integrated role of cardiac magnetic resonance and genetics in predicting left ventricular reverse remodelling in dilated and non-dilated cardiomyopathy 47
Sex Differences in Prognosis of Patients With Genetic Dilated Cardiomyopathy 43
Long-term outcomes and predictors of mortality in patients with chronic ischemic left ventricular dysfunction undergoing PCI: A multicenter study 40
Impact of genotype-phenotype associations on prognosis in dilated cardiomyopathy 38
What Should a Clinical Cardiologist Know About Cardiogenetics? 30
Predictors of Disease Progression in Patients with Left Ventricular Non-Dilated Cardiomyopathy 16
Twenty-Five-Year Follow-Up of the MDDC1 Family: A LMNA Gene Variant Associated With Dilated Cardiomyopathy With Variable Skeletal Muscle Involvement 12
Totale 12.678
Categoria #
all - tutte 33.826
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.826


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021121 0 0 0 0 0 0 0 0 0 65 25 31
2021/2022475 23 25 57 26 20 50 17 26 51 40 39 101
2022/20231.082 73 102 109 124 98 134 27 140 128 37 61 49
2023/20241.154 69 88 94 92 98 108 169 109 21 70 141 95
2024/20252.602 95 83 150 209 254 225 198 202 326 353 249 258
2025/20265.621 573 423 680 629 505 530 799 256 605 621 0 0
Totale 12.678